(Q45025906)

English

Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1 reference

based on heuristic

inferred from title

Tobias Banaschewski

3

object named as

Tobias Banaschewski

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Aribert Rothenberger

10

object named as

Aribert Rothenberger

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

14

object named as

Henrik Uebel

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Manfred Döpfner

1

object named as

Manfred Döpfner

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Wolff Dieter Gerber

2

object named as

Wolff Dieter Gerber

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Michael J. Gunter

7

object named as

Michael Günter

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

9

object named as

Claudia Ose

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

12

object named as

Judith Sinzig

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Dieter Breuer

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Franz Joseph Freisleder

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Gabi Gerber-von Müller

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Frank Hässler

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Klaus Schmeck

11

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Christina Stadler

13

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Gerd Lehmkuhl

15

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

European Child & Adolescent Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

13 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

I93-101

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

https://scigraph.springernature.com/pub.10.1007/s00787-004-1009-3

0 references

The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and metaanalyses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended-release methylphenidate (Ritalin LA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained release methylphenidate: pharmacokinetic studies in ADDH males

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empirically supported psychosocial treatments for attention deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Evidence based therapy of children and adolescents with attention deficit/hyperactivity hyperkinetic syndrome (ADHS)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does a morning dose of Methylphenidate Retard reduce hyperkinetic symptoms in the afternoon?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How do Hyperactive Children Feel About Taking Stimulants and Will They Tell the Doctor?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of an adaptive multimodal treatment in children with Attention-Deficit Hyperactivity Disorder -- global outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analog classroom assessment of Adderall in children with ADHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322960

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00787-004-1009-3

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45025906&oldid=2063381075"